z-logo
Premium
Immunotherapy with histamine dihydrochloride and low‐dose interleukin‐2 favors sustained lymphocyte recovery in acute myeloid leukemia
Author(s) -
Hallner Alexander,
Aurelius Johan,
Thorén Fredrik Bergh,
Sander Frida Ewald,
Brune Mats,
Hellstrand Kristoffer,
Martner Anna
Publication year - 2015
Publication title -
european journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 84
eISSN - 1600-0609
pISSN - 0902-4441
DOI - 10.1111/ejh.12454
Subject(s) - medicine , myeloid leukemia , immunotherapy , transplantation , lymphocyte , immunology , leukemia , clinical trial , hematopoietic stem cell transplantation , histamine , oncology , gastroenterology , immune system

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom